Safety, influence on the endometrium, sonographic changes and bleeding profile after 13 cycles with the new drospirenone only pill (DOP) for contraception.

Pedro-Antonio RegidorEnrico ColliDimitar GeorgievRossen KoytchevWolfram Richter

Published in: Hormone molecular biology and clinical investigation (2020)

Drospirenone 4 mg film-coated tablet in a dosage regime of 24/4 days is, regarding endometrial histology, a safe drug. Trial registration: EudraCT Register number: 2013-002300-13.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
atrial fibrillation
room temperature
endometrial cancer
reduced graphene oxide
randomized controlled trial
adverse drug
open label
emergency department
drug induced
gold nanoparticles
optical coherence tomography